Piper Sandler Downgrades Kura Oncology (KURA) to Neutral, Following Earnings
Tweet Send to a Friend
Piper Sandler analyst Tyler Van Buren downgraded Kura Oncology (NASDAQ: KURA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
